{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:02:06Z","timestamp":1790168526358,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012239","name":"Hubei Technological Innovation Special Fund","doi-asserted-by":"publisher","award":["2024AFD236"],"award-info":[{"award-number":["2024AFD236"]}],"id":[{"id":"10.13039\/501100012239","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Pasteurized\n                    <jats:italic>Akkermansia muciniphila<\/jats:italic>\n                    is a clinically tractable postbiotic candidate, but its activity cannot be assigned to a single principle. Heat-stable Amuc_1100 is demonstrably retained in pasteurized cells, whereas the GLP-1-inducing protein P9, extracellular vesicles (AmEVs), membrane lipids, and diffusible metabolites are supported mainly by studies of live bacteria or isolated preparations, whose retention and activity in pasteurized products remain unestablished; together they create overlapping links between the intestinal niche and hepatic physiology. Liver-directed studies now extend this framework beyond indirect metabolic inference. In mice, pasteurized bacteria and Amuc_1100 improve steatosis and alcohol-associated liver injury, while AmEV-containing preparations attenuate experimental fibrosis. Acetate, propionate, and L-norleucine associated with\n                    <jats:italic>Akkermansia muciniphila<\/jats:italic>\n                    also engage defined hepatic metabolic or antioxidant pathways. Yet the contribution of each effector, its exposure-response relationship, and its strain dependence remain unresolved. Human studies still evaluate whole-cell preparations and report heterogeneous metabolic and weight-related outcomes rather than liver histology or validated MASLD efficacy endpoints, and they lack validated effector-level pharmacodynamic assays. Here, we integrate the evidence, define the principal causal and translational gaps, and identify experiments that could close them. Priorities include orthogonal effector deconvolution, measurement of effector exposure in stored clinical samples, and specifications that link strain and processing to potency. Purified effectors need not replace pasteurized cells. Instead,\n                    <jats:italic>A. muciniphila<\/jats:italic>\n                    should be developed as a measurable multi-effector system, allowing product format to be selected according to the indication and the evidence.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1956062","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:11:50Z","timestamp":1790165510000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pasteurized Akkermansia muciniphila as a candidate multi-effector pharmacological system in the gut-liver axis: evidence, unresolved causality, and translational priorities"],"prefix":"10.3389","volume":"17","author":[{"given":"Yifan","family":"Liu","sequence":"first","affiliation":[{"name":"Hubei University of Chinese Medicine","place":["Wuhan, China"]},{"name":"Hubei Province International Science and Technology Cooperation Base for Innovative Research and Development of Food and Drug Resources and Targeted Delivery","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Xu","sequence":"additional","affiliation":[{"name":"Hubei University of Chinese Medicine","place":["Wuhan, China"]},{"name":"Hubei Province International Science and Technology Cooperation Base for Innovative Research and Development of Food and Drug Resources and Targeted Delivery","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Seon","family":"Kim","sequence":"additional","affiliation":[{"name":"Korea Institute of Oriental Medicine","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Xu","sequence":"additional","affiliation":[{"name":"Hubei University of Chinese Medicine","place":["Wuhan, China"]},{"name":"Hubei Province International Science and Technology Cooperation Base for Innovative Research and Development of Food and Drug Resources and Targeted Delivery","place":["Wuhan, China"]},{"name":"Huangjiahu Hospital of Hubei University of Chinese Medicine","place":["Wuhan, China"]},{"name":"Hubei Shizhen Laboratory","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huikun","family":"Wu","sequence":"additional","affiliation":[{"name":"Hubei University of Chinese Medicine","place":["Wuhan, China"]},{"name":"Hubei Province International Science and Technology Cooperation Base for Innovative Research and Development of Food and Drug Resources and Targeted Delivery","place":["Wuhan, China"]},{"name":"Huangjiahu Hospital of Hubei University of Chinese Medicine","place":["Wuhan, China"]},{"name":"Hubei Shizhen Laboratory","place":["Wuhan, China"]},{"name":"Institute of Liver Diseases, Hubei Key Laboratory of Theoretical and Applied Research of Liver and Kidney in Traditional Chinese Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine","place":["Wuhan, China"]},{"name":"Hubei Provincial Clinical Research Center of Traditional Chinese Medicine for Liver Diseases","place":["Wuhan, China"]},{"name":"Affiliated Hospital of Hubei University of Chinese Medicine","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3389\/fmicb.2019.02155","article-title":"Akkermansia muciniphila-derived extracellular vesicles as a mucosal delivery vector for amelioration of obesity in mice","volume":"10","author":"Ashrafian","year":"2019","journal-title":"Front. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e088290","DOI":"10.1136\/bmjopen-2024-088290","article-title":"Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis","volume":"15","author":"Augustijn","year":"2025","journal-title":"BMJ Open"},{"key":"B3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-022-04985-7","article-title":"Akkermansia muciniphila phospholipid induces homeostatic immune responses","volume":"608","author":"Bae","year":"2022","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41578-019-0156-6","article-title":"Materials for oral delivery of proteins and peptides","volume":"5","author":"Brown","year":"2019","journal-title":"Nat. Rev. Mater"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1038\/emm.2017.282","article-title":"Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"104072","DOI":"10.1016\/j.fbio.2024.104072","article-title":"Pasteurized Akkermansia muciniphila and its outer membrane protein Amuc_1100 alleviate alcoholic liver disease through modulating gut microbiota and host metabolism","volume":"59","author":"Cheng","year":"2024","journal-title":"Food Biosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e70326","DOI":"10.1002\/mnfr.70326","article-title":"An integrated engineering approach to creating health-modulating postbiotics","volume":"70","author":"Chikindas","year":"2026","journal-title":"Mol. Nutr. Food Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gutjnl-2014-308778","article-title":"Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology","volume":"65","author":"Dao","year":"2016","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1080\/19490976.2020.1737307","article-title":"Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice","volume":"11","author":"Depommier","year":"2020","journal-title":"Gut Microbes"},{"key":"B11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s13205-025-04465-5","article-title":"Engineered Lactococcus lactis secreting a glucagon-like peptide-1-inducing protein P9 for amelioration of obesity in mice","volume":"15","author":"Di","year":"2025","journal-title":"3 Biotech."},{"key":"B12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/jat.4044","article-title":"Toxicological safety evaluation of pasteurized Akkermansia muciniphila","volume":"41","author":"Druart","year":"2021","journal-title":"J. Appl. Toxicol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e9632","DOI":"10.2903\/j.efsa.2025.9632","article-title":"Safety of an extension of use of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015\/2283","volume":"23","author":"Turck","year":"2025","journal-title":"EFSA J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1638771","DOI":"10.3389\/fmicb.2025.1638771","article-title":"Investigating the role of Akkermansia muciniphila Akk11 in modulating obesity and intestinal dysbiosis: a comparative study of live and pasteurized treatments","volume":"16","author":"Feng","year":"2025","journal-title":"Front. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13578-025-01525-4","article-title":"Combination of GLP-1 receptor agonist and Akkermansia muciniphila Akk11 reduces adiposity and ameliorates MASLD in T2D mice","volume":"16","author":"Gao","year":"2026","journal-title":"Cell Biosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"8411","DOI":"10.1038\/s41467-024-52683-x","article-title":"The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacity","volume":"15","author":"Garcia-Vello","year":"2024","journal-title":"Nat. Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"B19","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut\u2013liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0048421","DOI":"10.1128\/Spectrum.00484-21","article-title":"The protective effects of live and pasteurized Akkermansia muciniphila and its extracellular vesicles against HFD\/CCl4-induced liver injury","volume":"9","author":"Keshavarz Azizi Raftar","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e03004","DOI":"10.1128\/AEM.03004-19","article-title":"Akkermansia muciniphila prevents fatty liver disease, decreases serum triglycerides, and maintains gut homeostasis","volume":"86","author":"Kim","year":"2020","journal-title":"Appl. Environ. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"108184","DOI":"10.1016\/j.phrs.2026.108184","article-title":"Gut microbial extracellular vesicles modulate the development of metabolic dysfunction-associated steatohepatitis through the gut-liver axis","volume":"227","author":"Kwak","year":"2026","journal-title":"Pharmacol. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1863368","DOI":"10.3389\/fnut.2026.1863368","article-title":"Strain-dependent efficacy of pasteurized Akkermansia muciniphila in alleviating colitis reveals AKK2645 restores immune and microbial homeostasis","volume":"13","author":"Li","year":"","journal-title":"Front. Nutr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e2533286123","DOI":"10.1073\/pnas.2533286123","article-title":"Akkermansia muciniphila-derived L-norleucine modulates FABP1-dependent fatty acid transport","volume":"123","author":"Li","year":"","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"112458","DOI":"10.1016\/j.isci.2025.112458","article-title":"Akkermansia muciniphila ameliorates fatty liver through microbiota-derived \u03b1-ketoisovaleric acid metabolism and hepatic PI3K\/Akt signaling","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"key":"B26","doi-asserted-by":"publisher","first-page":"100031","DOI":"10.1016\/j.cpblue.2026.100031","article-title":"Microbial reprogramming of the gut-liver nexus in MASLD: lessons from Akkermansia muciniphila","volume":"1","author":"Liu","year":"2026","journal-title":"Cell Press Blue"},{"key":"B27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13062-025-00680-5","article-title":"The genus Akkermansia is populated by a multitude of biological species with a wide distribution in the animal kingdom","volume":"20","author":"Molteni","year":"2025","journal-title":"Biol. Direct"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1038\/s41591-026-04394-7","article-title":"Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial","volume":"32","author":"Mount","year":"2026","journal-title":"Nat. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.20517\/mrr.2024.09","article-title":"Pangenomic analysis identifies correlations between Akkermansia species and subspecies and human health outcomes","volume":"3","author":"Mueller","year":"2024","journal-title":"Microbiome Res. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41522-024-00564-y","article-title":"Akkermansia muciniphila in the small intestine improves liver fibrosis in a murine liver cirrhosis model","volume":"10","author":"Oguri","year":"2024","journal-title":"Npj Biofilms Microbiomes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0173004","DOI":"10.1371\/journal.pone.0173004","article-title":"Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function","volume":"12","author":"Ottman","year":"2017","journal-title":"PLoS ONE"},{"key":"B32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"149131","DOI":"10.1016\/j.bbrc.2023.149131","article-title":"Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in mice","volume":"684","author":"Qu","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1128\/AEM.04050-14","article-title":"Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer","volume":"81","author":"Reunanen","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2690689","DOI":"10.1080\/19490976.2026.2690689","article-title":"Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels","volume":"18","author":"Suenaert","year":"2026","journal-title":"Gut Microbes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41591-019-0439-x","article-title":"The pros, cons, and many unknowns of probiotics","volume":"25","author":"Suez","year":"2019","journal-title":"Nat. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"115940","DOI":"10.1016\/j.fct.2026.115940","article-title":"Safety evaluation of pasteurized Akkermansia muciniphila YGMCC2645","volume":"210","author":"Tian","year":"2026","journal-title":"Food Chem. Toxicol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1324565","DOI":"10.3389\/fmicb.2023.1324565","article-title":"Frequently asked questions about the ISAPP postbiotic definition","volume":"14","author":"Vinderola","year":"2024","journal-title":"Front. Microbiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"107593","DOI":"10.1016\/j.jsb.2020.107593","article-title":"The variable oligomeric state of Amuc_1100 from Akkermansia muciniphila","volume":"212","author":"Wang","year":"2020","journal-title":"J. Struct. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"100060","DOI":"10.1016\/j.lmd.2025.100060","article-title":"Akkermansia muciniphila extracellular vesicles: function and theranostic potential in disease","volume":"2","author":"Wang","year":"2025","journal-title":"LabMed Discov."},{"key":"B43","doi-asserted-by":"publisher","first-page":"102138","DOI":"10.1016\/j.anaerobe.2019.102138","article-title":"An Akkermansia muciniphila subtype alleviates high-fat diet-induced metabolic disorders and inhibits the neurodegenerative process in mice","volume":"61","author":"Wu","year":"","journal-title":"Anaerobe"},{"key":"B44","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1021\/acs.jnatprod.9b00949","article-title":"Scientific and regulatory approach to botanical drug development: a U.S. FDA perspective","volume":"83","author":"Wu","year":"","journal-title":"J. Nat. Prod."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1111\/1751-7915.14293","article-title":"Akkermansia muciniphila alleviates high-fat-diet-related metabolic-associated fatty liver disease by modulating gut microbiota and bile acids","volume":"16","author":"Wu","year":"2023","journal-title":"Microb. Biotechnol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3390\/microorganisms8091413","article-title":"Beneficial effects of newly isolated Akkermansia muciniphila strains from the human gut on obesity and metabolic dysregulation","volume":"8","author":"Yang","year":"2020","journal-title":"Microorganisms"},{"key":"B47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41564-021-00880-5","article-title":"Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice","volume":"6","author":"Yoon","year":"2021","journal-title":"Nat. Microbiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta\u2010analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"101790","DOI":"10.1016\/j.toxrep.2024.101790","article-title":"Lack of genotoxicity and subchronic toxicity in safety assessment studies of Akkermansia muciniphila formulation","volume":"13","author":"Yu","year":"2024","journal-title":"Toxicol. Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.cmet.2024.12.010","article-title":"Akkermansia muciniphila supplementation in patients with overweight\/obese type 2 diabetes: efficacy depends on its baseline levels in the gut","volume":"37","author":"Zhang","year":"2025","journal-title":"Cell Metab."},{"key":"B52","doi-asserted-by":"publisher","first-page":"loaf036","DOI":"10.1093\/lifemeta\/loaf036","article-title":"Propionic acid secreted by Akkermansia muciniphila alleviates hepatic fibrosis by antioxidant regulation across the gut\u2013liver axis","volume":"5","author":"Zhang","year":"2026","journal-title":"Life Metab."},{"key":"B53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.apsb.2024.10.010","article-title":"Akkermansia muciniphila-derived acetate activates the hepatic AMPK\/SIRT1\/PGC-1\u03b1 axis to alleviate ferroptosis in metabolic-associated fatty liver disease","volume":"15","author":"Zhuge","year":"2025","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1956062\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:11:52Z","timestamp":1790165512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1956062\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":53,"alternative-id":["10.3389\/fphar.2026.1956062"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1956062","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1956062"}}